| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |